155 related articles for article (PubMed ID: 18204435)
1. RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi.
Itakura E; Huang RR; Wen DR; Paul E; Wünsch PH; Cochran AJ
Mod Pathol; 2008 Mar; 21(3):326-33. PubMed ID: 18204435
[TBL] [Abstract][Full Text] [Related]
2. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.
Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
Melanoma Res; 1998 Aug; 8(4):337-43. PubMed ID: 9764809
[TBL] [Abstract][Full Text] [Related]
3. Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue.
Koh SS; Opel ML; Wei JP; Yau K; Shah R; Gorre ME; Whitman E; Shitabata PK; Tao Y; Cochran AJ; Abrishami P; Binder SW
Mod Pathol; 2009 Apr; 22(4):538-46. PubMed ID: 19270649
[TBL] [Abstract][Full Text] [Related]
4. "Stealth" melanoma cells in histology-negative sentinel lymph nodes.
Itakura E; Huang RR; Wen DR; Cochran AJ
Am J Surg Pathol; 2011 Nov; 35(11):1657-65. PubMed ID: 21997686
[TBL] [Abstract][Full Text] [Related]
5. Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction: a methodological study on lymph nodes from melanoma patients.
Abrahamsen HN; Steiniche T; Nexo E; Hamilton-Dutoit SJ; Sorensen BS
J Mol Diagn; 2003 Feb; 5(1):34-41. PubMed ID: 12552078
[TBL] [Abstract][Full Text] [Related]
6. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.
de Vries TJ; Fourkour A; Wobbes T; Verkroost G; Ruiter DJ; van Muijen GN
Cancer Res; 1997 Aug; 57(15):3223-9. PubMed ID: 9242453
[TBL] [Abstract][Full Text] [Related]
8. MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.
Hofbauer GF; Schaefer C; Noppen C; Böni R; Kamarashev J; Nestle FO; Spagnoli GC; Dummer R
Am J Pathol; 1997 Dec; 151(6):1549-53. PubMed ID: 9403705
[TBL] [Abstract][Full Text] [Related]
9. Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.
Goto Y; Ferrone S; Arigami T; Kitago M; Tanemura A; Sunami E; Nguyen SL; Turner RR; Morton DL; Hoon DS
Clin Cancer Res; 2008 Jun; 14(11):3401-7. PubMed ID: 18519770
[TBL] [Abstract][Full Text] [Related]
10. Quantitative relationships between pigment-related mRNA and biochemical melanoma markers in melanoma cell lines.
Johansson M; Takasaki A; Lenner L; Arstrand K; Kågedal B
Melanoma Res; 2002 Jun; 12(3):193-200. PubMed ID: 12140375
[TBL] [Abstract][Full Text] [Related]
11. Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells.
Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Schenk F; Franzke A; Atzpodien J; Buer J
Melanoma Res; 2000 Aug; 10(4):355-62. PubMed ID: 10985670
[TBL] [Abstract][Full Text] [Related]
12. RT-PCR detection of tyrosinase, gp100, MART1/Melan-A, and TRP-2 gene transcripts in peripheral blood of melanoma patients.
Samija M; Juretić A; Solarić M; Samija I; Bingulac-Popović J; Grahovac B; Stanec M; Oresić V
Croat Med J; 2001 Aug; 42(4):478-83. PubMed ID: 11471202
[TBL] [Abstract][Full Text] [Related]
13. Detection of tyrosinase mRNA in formalin-fixed, paraffin-embedded archival sections of melanoma, using the reverse transcriptase in situ polymerase chain reaction.
Guo J; Cheng L; Wen DR; Huang RR; Cochran AJ
Diagn Mol Pathol; 1998 Feb; 7(1):10-5. PubMed ID: 9646029
[TBL] [Abstract][Full Text] [Related]
14. Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.
Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
J Cutan Pathol; 1998 Apr; 25(4):204-9. PubMed ID: 9609139
[TBL] [Abstract][Full Text] [Related]
15. Development of a multiple-marker polymerase chain reaction assay for detection of metastatic melanoma in lymph node aspirates of dogs.
Catchpole B; Gould SM; Kellett-Gregory LM; Dobson JM
Am J Vet Res; 2003 May; 64(5):544-9. PubMed ID: 12755292
[TBL] [Abstract][Full Text] [Related]
16. Expression of insulin-like growth factor I (IGF-I) in nevi and melanomas.
Fleming MG; Howe SF; Graf LH
Am J Dermatopathol; 1994 Aug; 16(4):383-91. PubMed ID: 7978067
[TBL] [Abstract][Full Text] [Related]
17. Melanoma-associated antigens as messenger RNA detection markers for melanoma.
Sarantou T; Chi DD; Garrison DA; Conrad AJ; Schmid P; Morton DL; Hoon DS
Cancer Res; 1997 Apr; 57(7):1371-6. PubMed ID: 9102226
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction.
Ringhoffer M; Schmitt M; Karbach J; Jäger E; Oesch F; Arand M
Int J Oncol; 2001 Nov; 19(5):983-9. PubMed ID: 11604998
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical studies of conjunctival nevi and melanomas.
Jakobiec FA; Bhat P; Colby KA
Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry for PRAME in Dermatopathology.
Lezcano C; Jungbluth AA; Busam KJ
Am J Dermatopathol; 2023 Nov; 45(11):733-747. PubMed ID: 37856737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
